TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner.

导出 LinkOut

翻译打印收藏纠错

作者： Xinyu,Jiang ^[1] ; Wenfei,Du ^[1] ; Chenglong,Yang ^[1] ; Shuying,Wang ^[2] ; Yifei,Li ^[3] ; Xinzhuang,Shen ^[3] ; Xiaowen,Yang ^[1] ; Jie,Yao ^[4] ; Renle,Du ^[5] ; Xiaoyuan,Zhang ^[6] ; Yongming,Huang ^[7] ; Wenzhi,Shen ^[8]

作者单位： Key Laboratory of Precision Oncology in Universities of Shandong, Institute of Precision Medicine, Jining Medical University, Jining, 272067, China. ^[1] The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, 563000, China. ^[2] Surgery Teaching and Research Section, Clinical Medical School, Jining Medical University, Jining, 272067, China. ^[3] Department of Oncology, Jining Hospital of Traditional Chinese Medicine, Jining, 272000, China. ^[4] Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450052, China. ^[5] Key Laboratory of Precision Oncology in Universities of Shandong, Institute of Precision Medicine, Jining Medical University, Jining, 272067, China. xiaoyuan0321smile@163.com. ^[6] Department of General Surgery, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, 272067, China. huangym0524@163.com. ^[7] Key Laboratory of Precision Oncology in Universities of Shandong, Institute of Precision Medicine, Jining Medical University, Jining, 272067, China. shenwenzhi2011@126.com. ^[8]

关键词 ARHGAP29 Apoptosis Colorectal cancer GSK3β Proliferation RSK TBX21